Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Revascularization versus medical therapy for renal-artery stenosis.
ASTRAL Investigators; Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, Carr S, Chalmers N, Eadington D, Hamilton G, Lipkin G, Nicholson A, Scoble J. ASTRAL Investigators, et al. Among authors: wheatley k. N Engl J Med. 2009 Nov 12;361(20):1953-62. doi: 10.1056/NEJMoa0905368. N Engl J Med. 2009. PMID: 19907042 Free article. Clinical Trial.
Surgery for Parkinson's disease: lack of reliable clinical trial evidence.
Stowe RL, Wheatley K, Clarke CE, Ives NJ, Hills RK, Williams AC, Daniels JP, Gray R. Stowe RL, et al. Among authors: wheatley k. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):519-21. doi: 10.1136/jnnp.74.4.519. J Neurol Neurosurg Psychiatry. 2003. PMID: 12640080 Free PMC article. Review.
Dopamine agonist therapy in early Parkinson's disease.
Stowe RL, Ives NJ, Clarke C, van Hilten J, Ferreira J, Hawker RJ, Shah L, Wheatley K, Gray R. Stowe RL, et al. Among authors: wheatley k. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006564. doi: 10.1002/14651858.CD006564.pub2. Cochrane Database Syst Rev. 2008. PMID: 18425954 Review.
Adjuvant interferon for melanoma.
Wheatley K, Ives N. Wheatley K, et al. Ann Oncol. 2002 Aug;13(8):1319-20; author reply 1320. doi: 10.1093/oxfordjournals.annonc.a000325. Ann Oncol. 2002. PMID: 12181258 Free article. No abstract available.
Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.
Hancock BW, Wheatley K, Harris S, Ives N, Harrison G, Horsman JM, Middleton MR, Thatcher N, Lorigan PC, Marsden JR, Burrows L, Gore M. Hancock BW, et al. Among authors: wheatley k. J Clin Oncol. 2004 Jan 1;22(1):53-61. doi: 10.1200/JCO.2004.03.185. Epub 2003 Dec 9. J Clin Oncol. 2004. PMID: 14665609 Clinical Trial.
293 results